Global Spinal Muscular Atrophy Market By Product Type, By Product Application, By Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2021 To 2029

Published : Q1 2021 | Pages : 200+

Select License Type


Description

Key Companies

Biogen Idec
Pfizer
Isis Pharmaceuticals
Boehringer Ingelheim
F. Hoffmann-La Roche
Regeneron Pharmaceuticals

Segmentation Covered

By Type
Type I
Type II
Type III
Type IV

By Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others

By Treatment
Gene Therapy
Drug {Spinraza, RG6083 (Olesoxime), RG7916}

By Administration Route
Oral
Intrathecal

By Region

Asia-Pacific: China, Southeast Asia, India, Japan, Korea, Oceania
Europe : Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland
North America : United States, Canada, Mexico
Middle East & Africa : GCC, North Africa, South Africa
South America : Brazil, Argentina, Columbia, Chile, Peru

TABLE OF CONTENTS

Chapter 1 Global Spinal Muscular Atrophy Market Overview

1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Spinal Muscular Atrophy Market
1.4 Restraints for Spinal Muscular Atrophy Market
1.5 Opportunities for Spinal Muscular Atrophy Market
1.6 Trends for Spinal Muscular Atrophy Market
1.7 COVID-19 Impact Assessment on Spinal Muscular Atrophy Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global Spinal Muscular Atrophy Market Overview

2.1 Global Spinal Muscular Atrophy Market by Product Type
2.1.1 Global Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Spinal Muscular Atrophy Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Spinal Muscular Atrophy Market by End User
2.2.1 Global Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Spinal Muscular Atrophy Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Spinal Muscular Atrophy Market by Region
2.3.1 Global Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Spinal Muscular Atrophy Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Spinal Muscular Atrophy Market Outlook (2013-2029)
2.4.1 Global Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Spinal Muscular Atrophy Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Spinal Muscular Atrophy Market Y-o-Y Growth Rate by Region
2.8.2 Global Spinal Muscular Atrophy Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Spinal Muscular Atrophy Market Y-o-Y Growth Rate by End User
2.9 Global Spinal Muscular Atrophy Market Share Comparison (2013-2029)
2.9.1 Global Spinal Muscular Atrophy Market Share by Region
2.9.2 Global Spinal Muscular Atrophy Market Share by Product Type
2.9.3 Global Spinal Muscular Atrophy Market Share by End User

Chapter 3 North America Spinal Muscular Atrophy Market Overview

3.1 North America Spinal Muscular Atrophy Market by Product Type
3.1.1 North America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Spinal Muscular Atrophy Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Spinal Muscular Atrophy Market by End User
3.2.1 North America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Spinal Muscular Atrophy Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Spinal Muscular Atrophy Market by Region
3.3.1 North America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Spinal Muscular Atrophy Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Spinal Muscular Atrophy Market Outlook (2013-2029)
3.4.1 North America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Spinal Muscular Atrophy Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Spinal Muscular Atrophy Market Y-o-Y Growth Rate by Region
3.8.2 North America Spinal Muscular Atrophy Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Spinal Muscular Atrophy Market Y-o-Y Growth Rate by End User
3.9 North America Spinal Muscular Atrophy Market Share Comparison (2013-2029)
3.9.1 North America Spinal Muscular Atrophy Market Share by Region
3.9.2 North America Spinal Muscular Atrophy Market Share by Product Type
3.9.3 North America Spinal Muscular Atrophy Market Share by End User

Chapter 4 Europe Spinal Muscular Atrophy Market Overview

4.1 Europe Spinal Muscular Atrophy Market by Product Type
4.1.1 Europe Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Spinal Muscular Atrophy Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Spinal Muscular Atrophy Market by End User
4.2.1 Europe Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Spinal Muscular Atrophy Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Spinal Muscular Atrophy Market by Region
4.3.1 Europe Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Spinal Muscular Atrophy Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Spinal Muscular Atrophy Market Outlook (2013-2029)
4.4.1 Europe Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Spinal Muscular Atrophy Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Spinal Muscular Atrophy Market Y-o-Y Growth Rate by Region
4.8.2 Europe Spinal Muscular Atrophy Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Spinal Muscular Atrophy Market Y-o-Y Growth Rate by End User
4.9 Europe Spinal Muscular Atrophy Market Share Comparison (2013-2029)
4.9.1 Europe Spinal Muscular Atrophy Market Share by Region
4.9.2 Europe Spinal Muscular Atrophy Market Share by Product Type
4.9.3 Europe Spinal Muscular Atrophy Market Share by End User

Chapter 5 Asia Pacific Spinal Muscular Atrophy Market Overview

5.1 Asia Pacific Spinal Muscular Atrophy Market by Product Type
5.1.1 Asia Pacific Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Spinal Muscular Atrophy Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Spinal Muscular Atrophy Market by End User
5.2.1 Asia Pacific Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Spinal Muscular Atrophy Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Spinal Muscular Atrophy Market by Region
5.3.1 Asia Pacific Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Spinal Muscular Atrophy Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Spinal Muscular Atrophy Market Outlook (2013-2029)
5.4.1 Asia Pacific Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Spinal Muscular Atrophy Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Spinal Muscular Atrophy Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Spinal Muscular Atrophy Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Spinal Muscular Atrophy Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Spinal Muscular Atrophy Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Spinal Muscular Atrophy Market Share by Region
5.9.2 Asia Pacific Spinal Muscular Atrophy Market Share by Product Type
5.9.3 Asia Pacific Spinal Muscular Atrophy Market Share by End User

Chapter 6 South America Spinal Muscular Atrophy Market Overview

6.1 South America Spinal Muscular Atrophy Market by Product Type
6.1.1 South America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Spinal Muscular Atrophy Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Spinal Muscular Atrophy Market by End User
6.2.1 South America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Spinal Muscular Atrophy Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Spinal Muscular Atrophy Market by Region
6.3.1 South America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Spinal Muscular Atrophy Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Spinal Muscular Atrophy Market Outlook (2013-2029)
6.4.1 South America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Spinal Muscular Atrophy Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Spinal Muscular Atrophy Market Y-o-Y Growth Rate by Region
6.8.2 South America Spinal Muscular Atrophy Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Spinal Muscular Atrophy Market Y-o-Y Growth Rate by End User
6.9 South America Spinal Muscular Atrophy Market Share Comparison 2013-2029
6.9.1 South America Spinal Muscular Atrophy Market Share by Region
6.9.2 South America Spinal Muscular Atrophy Market Share by Product Type
6.9.3 South America Spinal Muscular Atrophy Market Share by End User

Chapter 7 MEA Spinal Muscular Atrophy Market Overview

7.1 MEA Spinal Muscular Atrophy Market by Product Type
7.1.1 MEA Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Spinal Muscular Atrophy Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Spinal Muscular Atrophy Market by End User
7.2.1 MEA Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Spinal Muscular Atrophy Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Spinal Muscular Atrophy Market by Region
7.3.1 MEA Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Spinal Muscular Atrophy Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Spinal Muscular Atrophy Market Outlook (2013-2029)
7.4.1 MEA Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Spinal Muscular Atrophy Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Spinal Muscular Atrophy Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Spinal Muscular Atrophy Market Y-o-Y Growth Rate by Region
7.8.2 MEA Spinal Muscular Atrophy Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Spinal Muscular Atrophy Market Y-o-Y Growth Rate by End User
7.9 MEA Spinal Muscular Atrophy Market Share Comparison (2013-2029)
7.9.1 MEA Spinal Muscular Atrophy Market Share by Region
7.9.2 MEA Spinal Muscular Atrophy Market Share by Product Type
7.9.3 MEA Spinal Muscular Atrophy Market Share by End User

Chapter 8 Global Spinal Muscular Atrophy Market Company Profiles

8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis

Companies Included:
Biogen Idec
Pfizer
Isis Pharmaceuticals
Boehringer Ingelheim
F. Hoffmann-La Roche
Regeneron Pharmaceuticals

Chapter 9 Methodology and Data Source

9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

FOR MORE INFORMATION

Have a Question? Email us at

[email protected]

Or call us on

+1(925)478-7203

Credence Research Reports